Regorafenib hydrochloride is the hydrochloride salt of regorafenib, a potent multi-target kinase inhibitor. Supplied as an analytical standard for research use, it inhibits VEGFR1/2/3, PDGFRβ, Kit, RET, and Raf-1 with low-nanomolar potency, and is intended for in vitro and analytical applications such as HPLC, GC, and MS.
- Multi-target kinase inhibitor active against VEGFR1/2/3, PDGFRβ, Kit, RET, and Raf-1.
- Low-nanomolar potency reported for key kinase targets.
- High purity analytical standard (99.6%).
- Intended for research and analytical applications, including HPLC, GC, and MS.
- Suitable for method development and quantitative assays.